Which phases may not be undergone by all drugs?

Which phases may not be undergone by all drugs?

• A. Both Phase 4 and Phase 5 may not be undergone by all drugs.
• B. Phase 4 is mandatory for all; Phase 5 is always required.
• C. Phase 4 occurs before Phase 3.
• D. Phase 4 never changes formulation.

Answer: (A)

Understanding drug development phases helps explain why not every drug goes through every stage. Phase 4 is post-marketing surveillance that occurs after a drug is approved. It isn’t mandatory for all drugs; some products may be approved and marketed with limited or no formal Phase 4 studies, while others may enter Phase 4 to address safety signals, new indications, or labeling changes. Phase 5, on the other hand, isn’t a standard, universally defined phase in regulatory practice. Because there isn’t a required Phase 5 for all drugs, both phases may not be undertaken for every drug.

Understanding drug development phases helps explain why not every drug goes through every stage. Phase 4 is post-marketing surveillance that occurs after a drug is approved. It isn’t mandatory for all drugs; some products may be approved and marketed with limited or no formal Phase 4 studies, while others may enter Phase 4 to address safety signals, new indications, or labeling changes. Phase 5, on the other hand, isn’t a standard, universally defined phase in regulatory practice. Because there isn’t a required Phase 5 for all drugs, both phases may not be undertaken for every drug.